Echopixel Showcase
Sergio Aguirre Valencia
December, 2006.
This report is solely for the use of Echopixel Technologies personnel. No part of it may be circulated,quoted, or reproduced for distribution outside the organization without prior written approval from Echopixel Technologies
Problem we solve
Our 1st product is for Colon Cancer screening: • 90% of menand women over 50 are at risk • 60,000 deaths in the US • With early detection, 90% of cases are cured • Only 30% go through some kind of screening
There are 8,709 new people over 50 each dayProblem we solve
Colonoscopy WITH Complications
Colonoscopy with NO Complications
People don’t want to go through this…
The solution
– Navigate & Detect
Echopixel VED-CTM converts CATscans to 3D models of the colon and navigates through the body. • NON INVASIVE • Requires no preparation • Accurately detects pre-cancerous and cancerous polyps • Enhances screening capacity •Requires no physician time
The Solution
CAT Scan
Navigate & Detect
Value proposition
– New Market
Hospitals, HMO’s and imaging centers would:
• At least double their screeningcapacity • Directly reduce screening costs by 50% • Increase screening adherence beyond 30%
Saves millions in treatment & lives with early detection
Business Model
Outpatient Imaging Center
Cat ScanDatasets
Echopixel Teleradiology
$
3D Virtual Colonoscopy
Fast & reliable Virtual Colonoscopy evaluations by US accredited doctors and radiologists.
Management Team
• CEO, SergioAguirre Valencia • Founded Innouva Tech - fundraising & IP Building Management Team • Software Architect • Chief Medical Officer Building Board of Advisors • Simon Goldbard Ph.D. – founder of VitraBioscience and Applied Imaging. • Adolfo Nemirovsky Ph.D. – founder of Clearwater Networks and Flowstorm
What we need…
• “Smart money” Funding stages
• •
$500,000 US Dlls for Expanded Testing,...
Regístrate para leer el documento completo.